150 related articles for article (PubMed ID: 35060794)
1. COVID-19 and Sickle Cell Disease-Related Deaths Reported in the United States.
Payne AB; Schieve LA; Abe K; Hulihan M; Hooper WC; Hsu LL
Public Health Rep; 2022; 137(2):234-238. PubMed ID: 35060794
[TBL] [Abstract][Full Text] [Related]
2. Mortality related to sickle cell disease and COVID-19 in Brazil, 2020.
Santo AH
Rev Assoc Med Bras (1992); 2024; 70(4):e20231466. PubMed ID: 38747879
[TBL] [Abstract][Full Text] [Related]
3. Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017.
Payne AB; Mehal JM; Chapman C; Haberling DL; Richardson LC; Bean CJ; Hooper WC
Ann Emerg Med; 2020 Sep; 76(3S):S28-S36. PubMed ID: 32928459
[TBL] [Abstract][Full Text] [Related]
4. Description of a national, multi-center registry of patients with sickle cell disease and SARS-CoV-2 infection: Data from the Pediatric COVID-19 United States Registry.
Dain AS; Diorio C; Fisher BT; Hankins JS; Witmer CM; Boustany M; Burton M; Ferrolino J; Sadaf S; Ross HS; Maron G;
Pediatr Blood Cancer; 2024 Jun; 71(6):e30909. PubMed ID: 38469996
[TBL] [Abstract][Full Text] [Related]
5. Mortality rates and age at death from sickle cell disease: U.S., 1979-2005.
Lanzkron S; Carroll CP; Haywood C
Public Health Rep; 2013; 128(2):110-6. PubMed ID: 23450875
[TBL] [Abstract][Full Text] [Related]
6. COVID- 19 and sickle cell disease: autopsy findings of three deaths at the 37 Military Hospital, Accra, Ghana.
Attoh SA; Sarkodie E; Fatchu R; Kuma AB; Asumanu E; McAddy M; Toppar A; Hobenu F; Agyeman-Bediako K; Edusei L; Akakpo PK
Pan Afr Med J; 2022; 41():332. PubMed ID: 35865842
[TBL] [Abstract][Full Text] [Related]
7. Sickle cell disease related mortality in the United States (1999-2009).
Hamideh D; Alvarez O
Pediatr Blood Cancer; 2013 Sep; 60(9):1482-6. PubMed ID: 23637037
[TBL] [Abstract][Full Text] [Related]
8. Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002.
Yanni E; Grosse SD; Yang Q; Olney RS
J Pediatr; 2009 Apr; 154(4):541-5. PubMed ID: 19028391
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy.
Gibson S; Hunter T; Johnson N
Am J Trop Med Hyg; 2024 Jun; 110(6):1198-1200. PubMed ID: 38653217
[TBL] [Abstract][Full Text] [Related]
10. Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.
Minniti CP; Zaidi AU; Nouraie M; Manwani D; Crouch GD; Crouch AS; Callaghan MU; Carpenter S; Jacobs C; Han J; Simon J; Glassberg J; Gordeuk VR; Klings ES
Blood Adv; 2021 Jan; 5(1):207-215. PubMed ID: 33570644
[TBL] [Abstract][Full Text] [Related]
11. Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 2020.
Shiels MS; Haque AT; Haozous EA; Albert PS; Almeida JS; García-Closas M; Nápoles AM; Pérez-Stable EJ; Freedman ND; Berrington de González A
Ann Intern Med; 2021 Dec; 174(12):1693-1699. PubMed ID: 34606321
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors associated with COVID-19 related severity in sickle cell disease.
Yurtsever N; Nandi V; Ziemba Y; Shi PA
Blood Cells Mol Dis; 2021 Dec; 92():102627. PubMed ID: 34823201
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.
Boğa C; Asma S; Leblebisatan G; Şen N; Tombak A; Demiroğlu YZ; Yeral M; Akın Ş; Yeşilağaç H; Habeşoğlu MA; Arıboğan A; Kasar M; Korur A; Özdoğu H
Ann Hematol; 2021 Sep; 100(9):2195-2202. PubMed ID: 34032899
[TBL] [Abstract][Full Text] [Related]
14. Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease.
Lubeck D; Agodoa I; Bhakta N; Danese M; Pappu K; Howard R; Gleeson M; Halperin M; Lanzkron S
JAMA Netw Open; 2019 Nov; 2(11):e1915374. PubMed ID: 31730182
[TBL] [Abstract][Full Text] [Related]
15. Non-COVID-19 excess deaths by age and gender in the United States during the first three months of the COVID-19 pandemic.
Jacobson SH; Jokela JA
Public Health; 2020 Dec; 189():101-103. PubMed ID: 33197730
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020.
Panepinto JA; Brandow A; Mucalo L; Yusuf F; Singh A; Taylor B; Woods K; Payne AB; Peacock G; Schieve LA
Emerg Infect Dis; 2020 Oct; 26(10):2473-2476. PubMed ID: 32639228
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID-19: A 2.5-year follow-up study.
Feit A; Gordon M; Alamuri TT; Hou W; Mitchell WB; Manwani D; Duong TQ
Eur J Haematol; 2023 Oct; 111(4):636-643. PubMed ID: 37492929
[TBL] [Abstract][Full Text] [Related]
18. Opioids are not a major cause of death of patients with sickle cell disease.
Ballas SK
Ann Hematol; 2021 May; 100(5):1133-1138. PubMed ID: 33758998
[TBL] [Abstract][Full Text] [Related]
19. Sickle cell disease and COVID-19: Susceptibility and severity.
Sayad B; Karimi M; Rahimi Z
Pediatr Blood Cancer; 2021 Aug; 68(8):e29075. PubMed ID: 34061431
[TBL] [Abstract][Full Text] [Related]
20. The excess burden of stroke in hospitalized adults with sickle cell disease.
Strouse JJ; Jordan LC; Lanzkron S; Casella JF
Am J Hematol; 2009 Sep; 84(9):548-52. PubMed ID: 19623672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
